Around 11 am today, a tractor trailer driving along I-35 in Salado struck a beam on the FM 2484 bridge, causing several beams to become loose and the bridge to collapse. According to reports from the Texas Department of Public Safety, at least two pickup trucks and three semi trucks were damaged in the accident.
Sadly, the driver of a pickup truck that was under the bridge when it collapsed died from his injuries. Three other victims were taken to nearby Scott & White Hospital to receive treatment, though the extent of their injuries has not been reported.
According to a spokesperson from the Texas Department of Transportation, the likely cause of the truck accident is that either the truck or the trailer it was pulling was too tall to safely pass under the bridge.
We will continue to monitor this situation and update with any new information.
The child of a Dilworth mother will undergo major heart surgery due to a heart condition that was allegedly the result of exposure to the anti-nausea medication Zofran while in utero, the Valley News Live reported on Tuesday, March 17.
In an interview, Kylee Riesen told reporters she was devastated after learning that her daughter’s heart is twice as big as it normally should be. In May, baby Arianah will have to undergo open heart surgery at the very young age of two years old. Riesen said Arianah’s condition might be a result of taking Zofran while she was pregnant to treat her severe nausea.
Several studies have established clear links between Zofran and birth defects, including congenital heart abnormalities. To learn more about taking legal action after your baby has been hurt by this dangerous drug, speak with an attorney at Williams Kherkher by calling 800-220-9341 today.
Qsymia is a popular weight management pill recently approved by the U.S. Food and Drug Administration to fight against obesity. However, an active ingredient of the drug, a potent cardiac stimulator called phentermine, has been linked to cardiovascular disorders. Among these disorders is increased heart rate even while at rest.
Several studies have already suggested that having an abnormally high resting heart rate presents unfavorable health outcomes. In a Norwegian study involving nearly 30,000 individuals without any history of cardiovascular diseases, researchers found that those with high resting heart rate were twice at risk of dying from ischemic heart disease than those with normal heart rate.
The complications of Qsymia could be fatal. At Williams Kherkher, we help victims of this dangerous pill hold the manufacturer legally accountable for all the damages they have incurred. To learn more about taking legal action after being hurt by this drug, call us at (800) 220-9341 today.
In a 10 out of 12 vote, a jury in Philadelphia asserted that Johnson & Johnson’s (J&J) Janssen Pharmaceuticals failed to warn patients and prescribers about the possible risk of gynecomastia among young males taking the atypical antipsychotic drug Risperdal, Market Watch reported on Friday, March 20.
The jury decision came after a three week trial over a case filed by a 19-year-old plaintiff who claimed that taking the antipsychotic drug from age six to ten led him to develop breasts, a condition know as gynecomastia. The company, however, concealed the risk from prescribers. According to the report, the patient stopped using the drug in 2006, the year when the U.S. Food and Drug Administration granted Risperdal approval for limited use in children and adolescents.
Since its FDA approval in 1993 and prior to 2006, Risperdal was only allowed for use in adults and was prescribed off-label to young patients.
If you believe Risperdal has caused your loved one to suffer from any adverse health condition, a lawyer at Williams Kherkher might be able to represent you in seeking justice and compensation. Call us at (800) 220-9341 to learn more about taking legal action today.
A new study conducted in the U.K. revealed obese women are 40% more likely to develop certain forms of cancer than those with a healthy weight, Yahoo! Health reported on Tuesday, March 17.
According to the study, some types of cancer that could be triggered by obesity are colon cancer, uterine cancer, post-menopausal breast cancer, gallbladder cancer, kidney cancer, and pancreatic cancer. The researchers say that 274 out of 1,000 obese women will be diagnosed with cancer, as compared to 194 out of 1,000 among women of a healthy weight.
Dr. Julie Sharp, the head of health information at Cancer Research U.K., stated that switching to a healthier lifestyle would help a lot in reducing cancer risk.
Unfortunately, weight is just one of the many different factors that might increase your risk of cancer. For instance, several studies have found strong correlations between ovarian cancer and the use of talcum powder products for feminine hygiene. If you think a diagnosis of ovarian cancer has been a result of talcum powder use, a lawyer at Williams Kherkher can look into your situation to see if you might be able to hold its manufacturer legally accountable for the damages you suffered. Call us at 800-220-9341 today to learn more about how we can help you.
Usually, urine is a light to warm yellow color. However, in some cases, individuals may notice that their urine changes its color to brown, pink, or red. Below are some of the possible causes of urine discoloration.
- Presence of blood in urine may happen to individuals with enlarged prostate, kidney cysts, urinary tract infections (UTI), and other health conditions.
- Individuals who engage in arduous exercise may experience urine discoloration.
- Individuals may also experience urine discoloration from ingesting certain medicines.
- Urine discoloration may happen to individuals who eat blackberries, beets, aloe, or too much fava bean.
Urine discoloration unfortunately is one of the adverse side effects linked to Xarelto use. Although urine discoloration is not a dangerous condition in and of itself, it may be indicative of greater health problems caused by Xarelto, including gastrointestinal bleeding.
If you believe that you have been harmed by this potentially dangerous medication, the lawyers of Williams Kherkher may work on your behalf for the funds you need to cover medical expenses and other damages. Call our offices at (800) 220-9341 today to learn more about taking action against a negligent drug maker.
Japan-based drug manufacturer Daiichi Sankyo agreed to settle $690,000 in a New Jersey court after the company allegedly bribed medical providers and speakers to urge them to prescribe their products, NJ.com reported on March 16.
The drug manufacturer was sued after a former employee-turned-whistleblower reveal that the company was courting doctors and speakers with expensive dinners and other perks to encourage them to prescribe the drugs Benicar, Azor, Welchol, and Tribenzor. The whistleblower’s revelation compelled many states in the U.S. to sue Daiichi Sankyo after government-run healthcare programs, including Medicaid, were defrauded. The amount is part of January’s $39 million civil settlement, and over half will go to the federal government for their portion of Medicaid sponsorship.
Patients who take Benicar medicine to prevent cardiovascular problems and stroke are at risk of suffering abrupt weight loss that can seriously damage their health. If you or someone you know taking Benicar have suffered negative side effects, the lawyers of Williams Kherkher may work for you. Find out how we may possibly help you seek financial compensation today by calling (800) 220-9341.
A Pennsylvania Superior Court rejected Janssen Pharmaceutical’s appeal regarding the damage award for the Topamax lawsuit filed by Haley Powell, the Patriot-News reported on March 16.
The Superior Court ruled that Haley Powell and husband Michael Gurley should be awarded the $11.6 million already granted by a jury after their son was born with a cleft lip due to Topamax use before Powell became pregnant. The couple claimed in the lawsuit they filed in 2011 that Janssen and medical providers failed to warn consumers about the birth defects linked to Topamax use. Powell, who was prescribed to take Topamax in 2005, stopped the medication in 2007 due to pregnancy. However, Powell’s son was born in 2008 with cleft lip defects. Though the couple’s son underwent surgical treatment, Senior Judge William Platt noted that the boy will have to undergo further treatment. Janssen reached dozens of Topamax settlements in Philadelphia court in 2014.
If you believe that your loved one sustained congenital defects due to a pregnant mother taking Topamax, the pharmaceutical legal team of Williams Kherkher may work for you in the pursuit of financial compensation from those responsible. Find out how we may help you pursue damage claims from negligent drug manufacturers today by calling (800) 220-9341.
An investigation conducted by the United States Food and Drug Administration revealed that some herbal medicines for erectile dysfunction sometimes contain twice the dosage of the ingredients that the drug Viagra has – invariably more than what doctors would usually prescribe, Medical Daily reported on March 10.
These herbal remedies are prescription drugs in disguise and, especially in the unregulated larger doses, can cause serious harm to those who use them.
The FDA refused to reveal the sources of their findings – whether the counterfeit drugs they uncovered came from a single shipment or if they were spread out through various drug rings.
Although these unregulated doses of Viagra’s active ingredient may cause people problems, Viagra itself has been found to cause undue health complications. In particular, the onset of melanoma has been linked to this male enhancement drug. If you have suffered health problems after taking Viagra, call the attorneys of Williams Kherkher at 800-220-9341 today, and learn about your legal options for recourse.
The United States Food and Drug Administration recently approved Triferic, a drug created by Wixom, Michigan-based company Rockwell Medical Technologies, Inc., that is intended to combat anemia in end-stage renal failure and chronic kidney disease patients, the Detroit News reported on March 14.
As a serious side effect of dialysis is creating iron-deficiency anemia in patients, Triferic may go a long way toward preventing this condition. It maintains hemoglobin levels while simultaneously replacing iron in dialysis-dependent patients. The drug, whose generic name is ferric pyrophosphate citrate, is the first of its kind to be approved by the FDA.
Health information services firm IMS Midas reported that as of 2013, around 452,000 people in the United States who were diagnosed with end-stage renal disease are receiving dialysis.
Unfortunately, not all drugs associated with dialysis have worked as they should. GranuFlo has caused serious conditions such as cardiac arrhythmia, metabolic alkalosis, and more to patients who used it during dialysis. If you have been adversely affected by this drug, call the attorneys of Williams Kherkher at 800-220-9341 today to learn about your legal options for recourse.